Xiao H. Shang
Beijing, 100084, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Delayed antiviral immune response in alveolar type 2 cells increases susceptibility to influenza virus in alveoli.
Journal: Chinese medical journal
Published: October 17, 2025
Role of the novel optoelectronic imaging tracing system in cervical cancer screening: preliminary outcomes of a multi-center study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 13, 2025
Rhinovirus-Associated Lower Respiratory Tract Infection in Hospitalized Adult Patients: A Retrospective Cohort Study.
Journal: The Journal of infectious diseases
Published: July 23, 2025
Low-dose lenvatinib plus toripalimab for patients with platinum-resistant recurrent ovarian cancer: preliminary results from a multicenter, phase II trial (NCT06241105).
Journal: Gynecologic oncology
Published: May 16, 2025
Ninjurin-1 mediates cell lysis and detrimental inflammation of PANoptosis during influenza A virus infection.
Journal: Signal transduction and targeted therapy
Published: January 24, 2025
Cytologic DNA methylation for managing minimally abnormal cervical cancer screening results.
Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
Published: November 24, 2024
Efficacy and Safety of Low-Dose Lenvatinib and Toripalimab in Patients With Recurrent Platinum-Resistant Ovarian Cancer: Study Protocol of a Multicenter, Open-Label, Single-Arm, Phase II Clinical Trial.
Journal: International journal of women's health
Published: October 24, 2024
Time-resolved scRNA-seq reveals transcription dynamics of polarized macrophages with influenza A virus infection and antigen presentation to T cells.
Journal: Emerging microbes & infections
Published: August 12, 2024
Whole genome doubling in adenomyosis.
Journal: Clinical and translational medicine
Published: June 02, 2024
Low-dose lenvatinib and anti-programmed cell death protein-1 combination therapy in patients with heavily pre-treated recurrent ovarian and endometrial cancer: a pilot study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 24, 2024
Last Updated: 09/26/2026